Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...

Familial ALS (FALS) runs in families. About 5% to 10% of people with amyotrophic lateral sclerosis have this type. Changes to a gene cause FALS. Parents pass the faulty gene to their children.

Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Amyotrophic Lateral Sclerosis.

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty ...

Siplizumab is under clinical development by ITB-Med and currently in Phase I for Amyotrophic Lateral Sclerosis.

Special to the TimesDespite devastating diagnoses, the ALS (amyotrophic lateral sclerosis) and MS (multiple sclerosis) residents at the Leonard Florence Center for Living face each day with optimism, ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, announced the completion of its Phase II(a) clinical ...

Suggested remit: To appraise the clinical and cost effectiveness of tofersen within its marketing authorisation for treating amyotrophic lateral sclerosis caused by superoxide dismutase 1 (SOD1) ...

Gleason, who was diagnosed with amyotrophic lateral sclerosis (ALS) in 2011 when he was 33 years old, has become an ...